Human papillomavirus, vaccines and women's health: questions and cautions

Lippman, Abby; Melnychuk, Ryan; Shimmin, Carolyn; Boscoe, Madeline
August 2007
CMAJ: Canadian Medical Association Journal;8/28/2007, Vol. 177 Issue 5, p484
Academic Journal
The article presents the authors' comments on human papillomavirus (HPV), HPV vaccines and women's health in Canada. They note that both, the incidence and mortality of cervical cancer have been declining in Canada, however, they vary between different groups of women. According to them, the nature of a vaccination program is dependent on the definition of clear goals. They recommend that the lack of financial resources must not prevent any woman from receiving the HPV vaccination.


Related Articles

  • Human papillomavirus vaccination in the UK. Kim, Jane J. // BMJ: British Medical Journal (International Edition);8/9/2008, Vol. 337 Issue 7665, p303 

    The author reflects on human papillomavirus vaccination in young females in the United Kingdom. She suggests that the vaccinations are expected to be beneficial and cost effective. She argues that it may be decades before the true effect of human papillomavirus vaccination on cervical cancer is...

  • Assessing the Environment for Introduction of Human Papillomavirus Vaccine in India. Jacob, Martha; Mawar, Nita; Menezes, Lysander; Kaipilyawar, Satish; Gandhi, Sanjay; Khan, Irfan; Patki, Manoj; Bingham, Allison; LaMontagne, D. Scott; Bagul, Rajani; Katendra, Tuman; Karandikar, Neelima; Madge, Varada; Chaudhry, Kishore; Paranjape, Ramesh; Nayyar, Anjali // Open Vaccine Journal;2010, Vol. 3, p96 

    This paper presents findings from a study conducted in 2007 and 2008 in two states in India: Andhra Pradesh and Gujarat. The objectives of the study were to: (i) design effective and appropriate HPV vaccine delivery systems for 10- to 14-year-old girls; (ii) design a communication strategy for...

  • The introduction of the human papillomavirus vaccine -- key issues. Peate, Ian // British Journal of Nursing;1/22/2009, Vol. 18 Issue 2, p86 

    The human papillomavirus (HPV) vaccine was introduced in to the national immunization programme at the beginning of the 2008/2009 school year, being offered routinely to all 12--13-year-old girls with the aim of protecting them against cervical cancer. There are two particularly high risk HPV...

  • Dutch experts refute claims that HPV vaccination is risky. Sheldon, Tony // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/21/2009, p682 

    The article reports on a 2009 decision from public health experts in the Netherlands to refute claims made against a new human papillomatous vaccination program which was implemented by the Dutch Institute of Public Health and the Environment. The claims suggested that the vaccinations are...

  • The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years. Brown, Darron R.; Kjaer, Susanne K.; Sigurdsson, Kristján; Iversen, Ole-Erik; Hernandez-Avila, Mauricio; Wheeler, Cosette M.; Perez, Gonzalo; Koutsky, Laura A.; Tay, Eng Hseon; Garcia, Patricía; Ault, Kevin A.; Garland, Suzanne M.; Leodolter, Sepp; Olsson, Sven-Eric; Tang, Grace W. K.; Ferris, Daron G.; Paavonen, Jorma; Steben, Marc; Bosch, F. Xavier; Dillner, Joakim // Journal of Infectious Diseases;4/1/2009, Vol. 199 Issue 7, p926 

    Background. Human papillomavirus (HPV)-6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18 -related cervical intraepithelial neoplasia (CIN) 1-3 or adenocarcinoma in situ (AIS). Here, its impact on CIN1-3/AIS associated with nonvaccine oncogenic HPV types was evaluated. Methods. We enrolled...

  • Filling the Gaps To Fight Cervical Cancer. Beres, Samantha // JNCI: Journal of the National Cancer Institute;4/16/2008, Vol. 100 Issue 8, p526 

    The article discusses about the steps being taken in combating against cervical cancer. According to the article, pap screening programs for women have significantly brought down the incidence of cervical cancer. There are also vaccines for human papillomavirus, which has been a cause of...

  • January is Cervical Cancer awareness month.  // Tennessee Tribune;1/20/2011, Vol. 22 Issue 3, p6B 

    The article offers information on the preventive measures for protection, symptoms, and risk factors of cervical cancer which is mostly acquired by women because of human papilloma virus infection.

  • HPV Vaccination and the Prevention of Cervical Cancer: The Long Road Ahead. Markman, Maurie // Journal of Women's Health (15409996);Nov2007, Vol. 16 Issue 9, p1366 

    The author reflects on the status of the human papillomavirus (HPV) vaccination and cervical cancer prevention programs in the U.S. The author states that there are several barriers in the promise of its management strategy like the unsettling relationship between the HPV infection and the...

  • What Women Need To Know About HPV And Cervical Cancer. Achong, M. Natalie // Ebony;Jul2007, Vol. 62 Issue 9, p146 

    The article offers information about the human papillomavirus (HPV) vaccine. HPV refers to a group of viruses that infect genital area and cause genital cancer. The HPV vaccine could prevent viral infections caused by 70 percent of high-risk viruses. Proposal for mandatory HPV vaccination for...

  • Health checks, not shots. Moss, Ralph W. // New Scientist;2/24/2007, Vol. 193 Issue 2592, p20 

    The article discusses the wisdom of the decision of Texas Governor Rick Perry, who signed into law in February 2007 a mandate that all 11 and 12 year old girls within the Texas public school system will be forced to be vaccinated with Gardasil. The vaccine was developed by Merck to vaccinate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics